Member Exclusive

Accelerating the development of protein degradation therapeutics

Kymera Therapeutics (MA, USA) announces partnership with GlaxoSmithKline (London, UK) for the development of protein degrading therapeutics.

Go to the profile of Jasmine Harris
Apr 05, 2018
0
0

Please sign in or register for FREE

No comments yet.